Netanya I. Pollock, MD
Areas of expertise: Endocrine late effects in survivors of childhood cancer
Locations: Main Building, Buerger Center for Advanced Pediatric Care
About Netanya I. Pollock, MD
Titles
Attending Physician
Certifications
Pediatrics – American Board of Pediatrics
Awards and Honors
2024, Pediatric Endocrine Society Rising Star Award
2021, Student Teaching Award, Harvard Medical School
2021, Way to Shine Award, Boston Children’s Hospita
2021, Presidential Poster, Pediatric Endocrine Society 2021 Meeting
2019, The Outstanding Resident Teacher Award, Harvard Medical School/ Beth Israel Deaconess Medical Center
2018, The Bert and Sally O’Malley Award for Outstanding Medical Research, University of Pittsburgh School of Medicine
2017, Alpha Omega Alpha, University of Pittsburgh School of Medicine
2017, Arnold Gold Humanism Honor Society Member, Charles Watson Chapter at University of Pittsburgh School of Medicine
2016, Student of the Month, University of Pittsburgh School of Medicine
2015, Klionsky Fellowship for Pathology Research, University of Pittsburgh School of Medicine
2015, Steven Phillips Award for Basic Science Research, University of Pittsburgh School of Medicine
2015, Dean’s Summer Research Fellowship, University of Pittsburgh School of Medicine
2012-2013, Order of Omega Greek Leadership Honor Society, Columbia University
2013, cum laude, Columbia University
Leadership and Memberships
Memberships in Professional Organizations
2020-present, Pediatric Endocrine Society
2019-present, American Medical Association
2017-present, American Academy of Pediatrics
Education & training
Medical Degree
MD - University of Pittsburgh School of Medicine, Pittsburgh, PA
Residency
Pediatrics - Boston Children’s Hospital, Boston Medical Center, Boston, MA
Fellowship
Endocrinology - Children's Hospital of Philadelphia, Philadelphia, PA
Publications
PubMed
Publications
2025
Gera S, Guo M, Xie Y, Pollock N, Song M, Weber DR, Denburg M, Zemel B, Mostoufi-Moab S. Assessing bone mineral density and cortical geometry using high-resolution peripheral quantitative computed tomography in pediatric survivors of high-risk neuroblastoma with severe growth failure. Bone. 2025 Jun;195:117468. doi:10.1016/j.bone.2025.117468. Epub 2025 Mar 24. PMID: 40139336.
Molony C, Pollock N, Mostoufi-Moab S, Ness KK, Chemaitilly W. Endocrine Late Effects: Consequence or Catalyst to Health Disparities in Childhood Cancer Survivors? Endocrinol Metab Clin North Am. 2025 Jun;54(2):307-314. doi: 10.1016/j.ecl.2025.02.017. Epub 2025 Mar 20. PMID: 40348571.
2024
Pollock NI, Song M, Wolf AJ, Li Y, Hawkes CP, Motamedi N, Denburg MR, Mostoufi-Moab S. Exploring
height outcomes with adjuvant aromatase inhibition in growth hormone-deficient male survivors of childhood cancer. Pediatr Blood Cancer. 2024 Aug;71(8):e31117. doi: 10.1002/pbc.31117. Epub 2024 May 28. PMID: 38804882; PMCID: PMC11294979
2022
Pollock NI, Bradford VR, Hambrick HR, O’Donnell KA. Facilitating chalk talks via visual teaching tools. Med Educ. 2022 May; 56(5): 571-572. doi:10.1111/medu.14762.Epub 2022 Mar 1. PMID: 35230723
2021
Pollock NI, Flamand Y, Zhu J, Millington, K, Stevenson K, Silverman LB, Vrooman LM, Cohen LE. Hyperglycemia during induction therapy for acute lymphoblastic leukemia is temporally linked to pegasparagase administration. Pediatr Blood Cancer. 2021 Dec 21; e29505. doi: 10.1002/pbc.29505. Epub ahead of print. PMID: 34931744
2018
Ekambaram P, Lee J, Hubel N, Pollock NI, Klei LR, Concel VJ, et al. The Carma3-Bcl10-Malt1 Signalosome drives NF-kB activation and aggressive phenotype in AGTR1-positive Breast cancer. Cancer Research. 2018 March 1; 78 (5): 1225-1240. PMID: 29259013
2017
Lee JY, Ekambaram P, Hu D, Pollock NI, Hubel NE, Bailey R, Lee AV, Oesterreich S, McAllister-Lucas LM, Lucas PC. Malt1 is a key mediator of Epithelial-Mesenchymal Transition in AGTR1-Positive Breast Cancer. American Society of Investigative Pathology. 2017 Oct; 187(10):2353-2353.
Sen M, Johnston P, Pollock NI, DeGrave K, Sonali J, Freilino M, et al. Mechanism of action of selective inhibitors of IL-6 induced Stat3 pathway in head and neck cancer cell lines. Journal of Chem Biol. 2017 May 11; 10 (3): 129-141. PMID: 28684999
Belfer I, Pollock NI, Martin J, Lim G, De La Cruz C, Van Londen G, et al. The effect of gastroretentive gabapentin (Gralise) on chronic pain after breast surgery: A proof of principle study. PAIN Reports. 2017 Apr 11; 2(3): e596. PMID 29392212
2016
LaPorte MG, Wang Z, Colombo R, Garzan A, Peshkov VA, Liang M, Johnston PA, Schurdak ME, Sen M, Camarco DP, Hua Y, Pollock NI, Lazo JS, Grandis JR, Wipf P, Huryn DM. Optimization of pyrazole-containing 1,2,4-triazolo-[3,4-b] thiadiazines, a new class of STAT3 pathway inhibitors. Bioorg Med Chem Lett. 2016 Aug 1; 26 (15): 2581-5. PMID: 27381083
2015
Pollock NI, Wang L, Wallweber G, Gooding WE, Huang W, Chenna A, et al. Increased Expression of HER2, HER3, and HER2:HER3 Heterodimers in HPV-Positive HNSCC Using a Novel Proximity-Based Assay: Implications for Targeted Therapies. Clin Cancer Res. 2015 Oct 15; 21 (20): 4597-606. PMID: 26138066
Sen M, Pollock NI, Black J, DeGrave KA, Wheeler S, Freilino ML, et al. JAK kinase inhibition abrogates STAT3 activation and head and neck squamous cell carcinoma tumor growth. Neoplasia. 2015 Mar; 17(3): 256-64. PMID: 25810010
Editorials, Reviews, Chapters
2021
Pollock NI, Cohen LE. Growth hormone deficiency and treatment in childhood cancer survivors. Frontiers in Endocrinology. 2021; 12: 1332. DOI =10.3389/fendo.2021.745932
2019
Pollock NI, author of Endocrinology chapter in “The Boston Children’s Combined Residency Program Handbook of 2019”
2015
Pollock NI, Grandis JR. HER2 as a therapeutic target in head and neck squamous cell carcinoma. Clin Cancer Res. 2015 Feb 1; 21 (3): 526-33. PMID: 25424855